Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Email Communication, April 4, 2010 - MenHibrix


Submission Type: BLA       Submission ID: 125363/0      Office: OVRR Product:
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
GlaxoSmithKline Biologicals
Telecon Date/Time: 04-Apr-2010 08:30 PM           Initiated by FDA? Yes
Telephone Number: Communication Category:
1. Information Request
Telecon Summary:
Request for additional reagents, missing documents and specific questions about SOPs
FDA Participants: Jason Humbert
Non-FDA Participants: Norris Pyle; Jody Gould, PhD Telecon Body:
Attached is a request for reagents, documents and questions for the ongoing in-support testing for STN 125363/0.
----------------------------------------------( b)(4)------------------:
1.   ---------------------------------------------------------------------------------------------------------------------------------(b)(4)--------------------------------------------------------------------------------
  • -----------------------------------------------------------------------------------------------------------------(b)(4)------------------------------------------------------------------------------------------------
2.   ----------------------------------(b)(4)----------------------------------------------------------------------------------------------------
  • -------------------------------------------------------------------------------------------------------------------------------(b)(4)------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------


1 Page Determined to be Not Releasable: (b)(4)


7.   “Haemophilus influenzae type B: Determination of the ----------------(b)(4)--- of Hib in the combos HibMenCY by –(b)(4)- PRR'P - TT –(b)(4)- analysis” SOP 9000010110
  • Please provide the temperature setting of the -----(b)(4)-------
  • Please provide the temperature setting of the -----(b)(4)-------
  • Please confirm that the correct lot number for -----(b)(4)-------is -----(b)(4)-------
  • Please confirm that the correct lot number for the internal control Hiberix (------------------(b)(4)---------------------------
 8.   (b)(4) Determination of Individual Polysaccharides in Final Container
HibMenCY by -----(b)(4)------” SOP 9000010603
  • Please provide a ----(b)(4)---- that illustrates an acceptable ---(b)(4)--- profile in as indicated in the SOP “5.8.1 Validity Criteria for the –(b)(4)”

Page Last Updated: 09/25/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English